Literature DB >> 15276098

Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy.

David Aguilar1, Samuel Z Goldhaber, Daniel J Gans, Andrew S Levey, Jerome G Porush, Julia B Lewis, Jean-Lucien Rouleau, Tomas Berl, Edmund J Lewis, Marc A Pfeffer.   

Abstract

During the Irbesartan Diabetic Nephropathy Trial, 1,387 participants with type 2 diabetes mellitus, hypertension, and nephropathy underwent serial electrocardiograms for the identification of Q-wave myocardial infarction (MI). During a mean follow-up of 2.5 years, 14 of 99 first nonfatal MIs in this group were clinically unrecognized, accounting for 14% of all first nonfatal MIs.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15276098     DOI： 10.1016/j.amjcard.2004.04.028

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  8 in total

1.  Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging.

Authors:  Veerawat Nomsawadi; Rungroj Krittayaphong
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-02-05       Impact factor: 1.468

2.  Relation of glycemic status with unrecognized MI and the subsequent risk of mortality: The Jackson Heart Study.

Authors:  R Brandon Stacey; Michael E Hall; Paul E Leaverton; Douglas D Schocken; Janice Zgibor
Journal:  Am J Prev Cardiol       Date:  2022-05-10

3.  Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Zhu-Ming Zhang; Pentti M Rautaharju; Ronald J Prineas; Carlos J Rodriguez; Laura Loehr; Wayne D Rosamond; Dalane Kitzman; David Couper; Elsayed Z Soliman
Journal:  Circulation       Date:  2016-05-16       Impact factor: 29.690

4.  Vulnerable blood in high risk vascular patients: study design and methods.

Authors:  Mary M McDermott; Philip Greenland; Kiang Liu; Lu Tian; David Green; Sanjiv J Shah; Mark Huffman; John Wilkins; Melina Kibbe; Yihua Liao; Chiang-Ching Huang; Christopher Skelly; Chad Jacobs; Walter McCarthy; Amanda Auerbach; Donald Lloyd-Jones
Journal:  Contemp Clin Trials       Date:  2014-04-08       Impact factor: 2.226

5.  Prognostic value of late gadolinium enhancement in hypertensive patients with known or suspected coronary artery disease.

Authors:  Rungroj Krittayaphong; Thananya Boonyasirinant; Vithaya Chaithiraphan; Adisak Maneesai; Pairash Saiviroonporn; Supaporn Nakyen; Prajak Thanapiboonpol; Ahthit Yindeengam; Suthipol Udompanturak
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-05       Impact factor: 2.357

6.  Abnormal Fasting Glucose Increases Risk of Unrecognized Myocardial Infarctions in an Elderly Cohort.

Authors:  Richard Brandon Stacey; Janice Zgibor; Paul E Leaverton; Douglas D Schocken; Jennifer A Peregoy; Mary F Lyles; Alain G Bertoni; Gregory L Burke
Journal:  J Am Geriatr Soc       Date:  2018-10-09       Impact factor: 5.562

Review 7.  The ECG vertigo in diabetes and cardiac autonomic neuropathy.

Authors:  Christina Voulgari; Nicholas Tentolouris; Christodoulos Stefanadis
Journal:  Exp Diabetes Res       Date:  2011-05-29

8.  Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study.

Authors:  Michael R MacDonald; Mark C Petrie; Philip D Home; Michel Komajda; Nigel P Jones; Henning Beck-Nielsen; Ramon Gomis; Markolf Hanefeld; Stuart J Pocock; Paula S Curtis; John J V McMurray
Journal:  Diabetes Care       Date:  2011-05-11       Impact factor: 19.112
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.